Metabolic syndrome among patients with type 2 diabetes in Jordan: A cross-sectional study
Dana Hyassat,Ala'a Al-Refai,Yousef S. Khader,Malik E. Juweid,Saja AlSharaydeh,Nadera Layyous,Husam Aljabiry,Ahmad AlDurgham,Laith Z. Baqain,Joud Abu Summaqa,Rana Al-Shimi,Fatima Mohammad Atieh,Awn Mahasneh,Shaker Alaraj,Alanoud Al-wakfi,Omar Mahafza,Mohammad EL-Khateeb,Kamel Ajlouni
DOI: https://doi.org/10.1097/md.0000000000040602
IF: 1.6
2024-11-28
Medicine
Abstract:Metabolic syndrome is typically defined as the cluster of abnormally high blood pressure (BP), increased fasting blood glucose (FBG), visceral obesity, high serum triglycerides (TG), and low serum high-density lipoprotein (HDL); the latter 2 being part of the atherogenic dyslipidemia triad. [ 1 ] It is associated with increased risk of type 2 diabetes mellitus (T2DM), stroke, congestive heart disease, myocardial infarction, and cardiovascular and all-cause mortality. [ 2 , 3 ] Metabolic syndrome is a major public health concern worldwide with prevalence rates ranging from as low as 10% to as high as 84% depending on the definition used and ethnic group. [ 1 , 4 ] In Jordan, the age-adjusted prevalence of metabolic syndrome was estimated at 44% according to the International Diabetes Federation (IDF) criteria and 39.9% according to the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) criteria, [ 5 ] which was in the upper range compared to other regional populations. [ 6–9 ] The literature on metabolic syndrome in diabetic patients in Jordan is relatively limited given its high prevalence in the general population, so this study was conducted to determine the prevalence and factors associated with metabolic syndrome and its individual elements in patients diagnosed with T2DM in Jordan.
medicine, general & internal